These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7875160)

  • 21. Secretory endometrial adenocarcinoma in a tamoxifen user with breast cancer after menopause.
    Wu CJ; Peng YJ; Yu MH; Chen CH
    Taiwan J Obstet Gynecol; 2007 Mar; 46(1):88-90. PubMed ID: 17389201
    [No Abstract]   [Full Text] [Related]  

  • 22. [Monitoring of postmenopausal women treated with tamoxifen for breast carcinoma].
    Epifani S; Lattarulo S; Maiorino R; Fabiano G
    G Chir; 2000; 21(6-7):310-2. PubMed ID: 10916956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endometrial adenocarcinoma appearing during tamoxifen therapy. Report of a clinical case].
    Menada MV; Corticelli A; Giannesi A; Nicoletti L; Podesta M; Rissone R; Fulcheri E
    Minerva Ginecol; 2000 Dec; 52(12):521-6. PubMed ID: 11310150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.
    Robinson DC; Bloss JD; Schiano MA
    Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asymptomatic carcinoma of the endometrium in a patient on adjunctive tamoxifen therapy for carcinoma of the breast.
    O'Neill E; Rodríguez Mojica W
    Bol Asoc Med P R; 1992 Feb; 84(2):74-7. PubMed ID: 1388459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial cancer in patients with breast carcinoma treated with tamoxifen: report of two cases and the literature overview.
    Sliwińska M; Wojtacki J; Sliwiński W
    Med Sci Monit; 2000; 6(2):399-406. PubMed ID: 11208346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasound, tamoxifen and endometrial carcinoma.
    Ghirardini G; Bianchini A; Rossi GP
    Ultrasound Obstet Gynecol; 1999 May; 13(5):375-6. PubMed ID: 10380310
    [No Abstract]   [Full Text] [Related]  

  • 28. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 29. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aromatase inhibitors alone or sequentially combined with tamoxifen in postmenopausal early breast cancer compared with tamoxifen or placebo - Meta-analyses on efficacy and adverse events based on randomized clinical trials.
    Rydén L; Heibert Arnlind M; Vitols S; Höistad M; Ahlgren J
    Breast; 2016 Apr; 26():106-14. PubMed ID: 27017249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraepithelial G3 adenocarcinoma of the endometrium after tamoxifen treatment.
    Marchesoni D; Driul L; Mozzanega B; Nardelli GB; Parenti A
    Arch Gynecol Obstet; 2005 Jan; 271(1):62-5. PubMed ID: 15290168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is tamoxifen associated with high-risk endometrial carcinomas? A retrospective case series of 196 women with endometrial cancer.
    Rieck GC; Freites ON; Williams S
    J Obstet Gynaecol; 2005 Jan; 25(1):39-41. PubMed ID: 16147692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tamoxifen and endometrial cancer. A case report].
    Orbo A; Lindal S; Mortensen E
    Tidsskr Nor Laegeforen; 1996 Jun; 116(16):1877-8. PubMed ID: 8711699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of correlation between risk factors for endometrial cancer and the presence of tamoxifen-associated endometrial polyps in postmenopausal patients with breast cancer.
    Timmerman D; Deprest J; Verbesselt R; Moerman P; De Brabanter J; Vergote I
    Eur J Cancer; 2000 Sep; 36 Suppl 4():S40-2. PubMed ID: 11056312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients].
    Otsuka I; Takahashi S; O'uchi K; Akimoto N; Hanari K; Ogaki Y; Enatsu YH; Takigawa A; Takaya H; Tanaka A; Kaseki H; Yamada T
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):279-83. PubMed ID: 20154485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients.
    Cohen I; Bernheim J; Azaria R; Tepper R; Sharony R; Beyth Y
    Gynecol Oncol; 1999 Oct; 75(1):136-41. PubMed ID: 10502440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring.
    Vosse M; Renard F; Coibion M; Neven P; Nogaret JM; Hertens D
    Eur J Obstet Gynecol Reprod Biol; 2002 Feb; 101(1):58-63. PubMed ID: 11803101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endometrial carcinoma in tamoxifen-treated breast cancer patients.
    Spinelli G; Bardazzi N; Citernesi A; Fontanarosa M; Curiel P
    J Chemother; 1991 Aug; 3(4):267-70. PubMed ID: 1779263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Breast cancer, tamoxifen, and uterus].
    Palacios A; Pertusa S; Montoya A; Martínez San Pedro R
    Med Clin (Barc); 1993 Mar; 100(12):479. PubMed ID: 8479228
    [No Abstract]   [Full Text] [Related]  

  • 40. Expression of the epidermal growth factor system in endometrial cancer after adjuvant tamoxifen treatment for breast cancer.
    Androutsopoulos G; Adonakis G; Gkermpesi M; Gkogkos P; Ravazoula P; Kourounis G
    Eur J Gynaecol Oncol; 2006; 27(5):490-4. PubMed ID: 17139985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.